Empagliflozin
Empagliflozin Price range: $ 153,00 through $ 727,00
Back to products
Emulgel
Emulgel Price range: $ 51,00 through $ 323,00

Emsam

Price range: $ 66,00 through $ 345,00

Emsam is an advanced transdermal patch designed specifically for the treatment of major depressive disorder in adults. As a unique skin patch, it delivers the active medication selegiline directly into the bloodstream over a continuous twenty-four-hour period. This monoamine oxidase inhibitor works by restoring the balance of certain natural chemicals in the brain to help improve mood and emotional outlook. The once-daily application provides a steady release of medicine, ensuring consistent levels throughout the day and night. It offers a modern and effective approach for individuals seeking a specialized option for managing symptoms of clinical depression.

Active substance: Selegiline
SKU: Emsam Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Emsam belongs to a class of medications known as monoamine oxidase inhibitors (MAOIs). It is an FDA-approved transdermal patch designed for the management of major depressive disorder in adults.

As a prescription-only therapy, Emsam delivers selegiline continuously through the skin over a 24-hour period to help regulate key neurotransmitters in the brain.

Basic Information

Property Details
Active Ingredient Selegiline
Dosage Form Transdermal system (patch)
Route of Administration Transdermal
Primary Purpose Treatment of major depressive disorder (MDD)
Prescription Status Prescription only (Rx)
Storage Conditions Store at 20°C to 25°C (68°F to 77°F)

How the Drug Works

Emsam contains selegiline, an irreversible inhibitor of the enzyme monoamine oxidase (MAO). Monoamine oxidase plays a central role in the breakdown of monoamine neurotransmitters, including norepinephrine, serotonin, and dopamine, within the central nervous system. By inhibiting this enzymatic activity, Emsam increases the concentrations and functional availability of these neurochemicals in synaptic pathways involved in mood regulation.

At the lowest recommended target dose of 6 mg/24 hours, Emsam primarily functions as a selective inhibitor of MAO-B. At higher therapeutic dosages, such as 9 mg/24 hours or 12 mg/24 hours, selegiline loses its selectivity and significantly inhibits both MAO-A and MAO-B. MAO-A inhibition in the gastrointestinal tract and liver alters systemic metabolism of dietary amines, which underlies specific dietary precautions required at higher doses.

Main Uses

Emsam is indicated strictly for the treatment of major depressive disorder (MDD) in adult patients. MDD is characterized by persistent depressive mood, loss of interest in daily activities, significant alterations in sleep or appetite, impaired concentration, and physical fatigue. Therapy aims to reduce the severity of these symptoms and restore functional capacity.

The safety and effectiveness of Emsam in pediatric patients (under 18 years of age) have not been established, and the medication is not approved for pediatric major depressive disorder. Any use of Emsam outside of the FDA-approved indication for adult MDD is categorized as off-label and must be evaluated on an individual basis by a qualified healthcare provider.

Dosing Schedule

Emsam is formulated as a transdermal system available in three distinct dose strengths: 6 mg/24 hours, 9 mg/24 hours, and 12 mg/24 hours. The standard recommended starting dose and maintenance target for most adults is 6 mg/24 hours. If clinical response is insufficient after adequate trial periods, dose increases may be evaluated in increments of 3 mg/24 hours at intervals of no less than two weeks, up to a maximum dose of 12 mg/24 hours.

A single patch must be applied to clean, dry, intact skin once every 24 hours. Recommended application sites include the upper torso, outer upper arm, or upper thigh. Application sites should be rotated daily to minimize local skin irritation. Patches should never be cut, trimmed, or damaged prior to application.

How It’s Absorbed and Eliminated

Following transdermal administration, selegiline is continuously absorbed through the stratum corneum into the systemic bloodstream over the 24-hour application window. Transdermal administration bypasses extensive first-pass hepatic and intestinal metabolism, yielding significantly higher systemic bioavailability of parent selegiline compared to equivalent oral formulations.

Once absorbed, selegiline undergoes extensive hepatic metabolism into active and inactive metabolites, including N-desmethylselegiline, methamphetamine, and amphetamine. These metabolites are subsequently cleared from the body primarily via renal excretion in the urine. Steady-state plasma concentrations of selegiline are typically achieved after several consecutive days of daily patch replacements.

What Not to Combine

Combining Emsam with specific pharmacological agents is strictly contraindicated due to risks of life-threatening reactions such as hypertensive crisis or serotonin syndrome. Emsam must not be administered concurrently with other antidepressants, including selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, or other MAOIs.

Co-administration with potent opioid analgesics such as meperidine, tramadol, or methadone, as well as the cough suppressant dextromethorphan, is prohibited. Sympathomimetic amines found in prescription and over-the-counter decongestants (such as pseudoephedrine or phenylephrine) must also be avoided. A minimum washout period of 14 days is required when transitioning between Emsam and most other antidepressant regimens, whereas a 5-week washout period is mandated after discontinuing fluoxetine prior to starting Emsam.

What Side Effects May Occur

Clinical trials have documented a range of potential adverse effects associated with Emsam therapy. The most common localized adverse event reported is application site reaction, which typically manifests as mild to moderate erythema, itching, or skin irritation at the patch placement location.

Systemic side effects reported during treatment include:

  • Insomnia and sleep disturbances
  • Dry mouth (xerostomia)
  • Diarrhea and dyspepsia
  • Dizziness and lightheadedness
  • Orthostatic hypotension (sudden drop in blood pressure upon standing)

As with other antidepressant agents, activation of mania or hypomania may occur in individuals with undetected bipolar risk factors.

Important Precautions

Emsam carries a boxed warning regarding the increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults taking antidepressant medications. Prescribers and caregivers must closely monitor all patients initiating therapy for clinical worsening, sudden behavior shifts, or emergent suicidality, particularly during the first few months of treatment or following dose adjustments.

Care should be exercised in elderly populations, where age-related declines in hepatic or renal clearance may alter drug exposure, increasing susceptibility to orthostatic blood pressure changes. Emsam should be used during pregnancy only if the potential therapeutic benefit justifies the potential risk to the fetus. Nursing mothers should discuss with their prescriber whether to discontinue nursing or discontinue the drug, balancing clinical necessity against infant exposure risks.

What to Avoid While Taking It

Dietary management during Emsam therapy is directly contingent upon the prescribed dosage strength. For patients receiving the lowest strength of 6 mg/24 hours, dietary tyramine restrictions are generally not required because MAO-A in the gut remains largely uninhibited.

However, for patients prescribed the 9 mg/24 hours or 12 mg/24 hours patches, strict adherence to a tyramine-restricted diet is mandatory. Ingestion of high-tyramine foods–such as aged cheeses, air-dried or fermented meats, tap beer, yeast extracts, and unpasteurized soy products–can trigger severe hypertensive crisis due to systemic accumulation of pressor amines. Alcohol consumption should be avoided across all dosage strengths due to heightened central nervous system depression risks.

Red Flags

Patients and caregivers must seek immediate emergency medical care if any symptoms indicative of a hypertensive crisis or serotonin syndrome develop. Key warning signs requiring emergency medical attention include:

  • Severe, sudden headache accompanied by neck stiffness or soreness
  • Chest pain, rapid heart rate, or irregular heart palpitations
  • Severe nausea, vomiting, or heavy sweating combined with high fever
  • Dilated pupils, severe mental confusion, or extreme agitation
  • Difficulty breathing or swelling of the face, lips, tongue, or throat

First Days of Treatment

During the initial phase of Emsam therapy, patients often experience mild skin redness or minor itching under the patch. Therapeutic antidepressant effects are not instantaneous; noticeable improvements in mood, sleep patterns, and daily energy levels generally require several weeks of continuous daily administration.

Patients are advised to maintain daily patch replacement schedules as prescribed, even if therapeutic benefits are not immediately apparent during the first two weeks. Mild lightheadedness when transitioning from sitting to standing positions may occur early in treatment, warranting cautious physical movements to prevent falls.

Storage and Expiration

Emsam transdermal systems should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). Transdermal patches must remain sealed inside their individual protective pouches until immediately prior to application on the skin.

Patches must be kept away from direct heat sources, including heating pads, electric blankets, saunas, or prolonged direct sunlight, as elevated skin temperature accelerates drug absorption into the bloodstream. Keep out of reach of children and domestic pets. Used patches should be folded in half so that the adhesive side sticks to itself before being safely discarded in domestic trash.

Common Questions

What should I do if the patch falls off before 24 hours?

If an Emsam patch falls off prematurely, apply a fresh patch to a new, undamaged skin site on your upper torso, outer upper arm, or upper thigh. Continue wearing this new patch until your standard scheduled patch replacement time the following day. Maintain your regular daily application schedule thereafter.

Can I swim, bathe, or shower while wearing Emsam?

Yes, brief contact with water during showering or bathing generally does not compromise patch adherence or drug release. However, prolonged soaking in hot tubs or swimming should be minimized, and direct heat exposure must be avoided to prevent excess drug absorption.

How long does selegiline remain active in the body after removing the patch?

Selegiline binds irreversibly to monoamine oxidase enzymes. Even after removing the patch, enzyme recovery requires the body to synthesize new MAO proteins, a process that typically takes up to two weeks. Consequently, drug interaction risks and dietary restrictions (for 9 mg/24h and 12 mg/24h doses) persist for 14 days after discontinuing Emsam.

Is it safe to drive or operate machinery while using Emsam?

Emsam may cause dizziness, drowsiness, or postural hypotension in some individuals. Patients should avoid operating motor vehicles or hazardous machinery until they have determined how the medication affects their physical reflexes and mental alertness.

What happens if I accidentally miss a daily patch application?

If you forget to apply a new patch at your usual scheduled time, apply a fresh patch as soon as you remember. If it is almost time for your next scheduled application, skip the missed patch and resume your regular daily schedule. Never apply two patches simultaneously to compensate for a missed dose.

In accordance with FDA requirements.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

Additional information
Dosage

5mg

Package

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία